ஃபிஜி காவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fiji Kava (ASX:FIJ) partners with iTaukei to develop supply chain in Fiji

Fiji Kava (ASX:FIJ) partners with iTaukei to develop supply chain in Fiji
themarketherald.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketherald.com.au Daily Mail and Mail on Sunday newspapers.

Itaukei trust fund boardFiji kavaNoble kavaFiji governmentNoble kavaஃபிஜி காவஉன்னத காவஃபிஜி அரசு

Fiji Kava (ASX:FIJ) drives down loss amid revenue increase in FY21

Fiji Kava (ASX:FIJ) ended the 2021 financial year with a reductions in its net loss, after increasing its revenue by 52 per cent.

Fiji kavaNoble kava capsulesChemist warehousesKavaa noble kavaChief executive officer anthony nobleஃபிஜி காவவேதியியலாளர் கிடங்குகள்

Fiji Kava Ltd forms strategic partnership with Chemist Warehouse Group

Fiji Kava Ltd forms strategic partnership with Chemist Warehouse Group
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

New zealandFiji kava ltdChemist warehouse groupChemist warehouseFiji kavaAnthony nobleTmall globalJack ganceNoble kavaNoble sleepNoble calmNoble bodyAlibaba tmall globalபுதியது ஜீலாந்துஃபிஜி காவ லிமிடெட்வேதியியலாளர் கிடங்கு குழு

Fiji Kava Ltd forms strategic partnership with Chemist Warehouse Group

New zealandChemist warehouse groupChemist warehouseFiji kavaAnthony nobleTmall globalJack ganceNoble kavaNoble sleepNoble calmNoble bodyAlibaba tmall globalபுதியது ஜீலாந்துவேதியியலாளர் கிடங்கு குழுவேதியியலாளர் கிடங்குஃபிஜி காவ

Fiji Kava (ASX:FIJ) appoints Dr Anthony Noble as CEO

Fiji Kava (ASX:FIJ) appoints Dr Anthony Noble as CEO SubscribeBe the first with the news that moves the market Medicinal kava company Fiji Kava (FIJ) has appointed Dr Anthony Noble as CEO, effective May 31, 2021 Dr Anthony will be taking over from interim CEO Nicholas Simms, who will transition back to his role of Non-Executive Director Currently, Dr Anthony is the CEO and Managing Director of Australian Biotherapeutics, roles in which he has been in since 2019 Dr Anthony has also worked at SFI Group, Cryosite and in the U.K. at the Human Tissue Authority Shares in Fiji Kava are up 7.69 per cent on the market and are trading at 14 cents

Nicholas simmsGroup head of north asiaHuman tissue authorityFiji kavaManaging directorHuman tissueGlobal headNorth asiaGeneral managerநிக்கோலஸ் சிம்ஸ்மனிதன் திசு அதிகாரம்ஃபிஜி காவநிர்வகித்தல் இயக்குனர்மனிதன் திசுஉலகளாவிய தலைவடக்கு ஆசியா